Takeda Pharmaceutical Co Ltd (4502.T)
17 Aug 2018
* Shire-related costs helped push debt ratio higher (Adds details from news conference)
TOKYO, July 31 Japan's Takeda Pharmaceutical Co Ltd on Tuesday reported a 49 percent fall in first-quarter operating profit, affected by asset sales booked in the same quarter a year earlier and by generic drug competition for blood cancer treatment Velcade in the U.S.
LONDON/TOKYO The trade is familiar to investors worldwide: in times of turmoil, rush for cover by buying the Japanese yen.
TOKYO Takeda Pharmaceutical Co Ltd on Tuesday said it has received U.S. approval for its $62 billion acquisition of London-listed Shire Plc, taking the Japanese firm one step closer to its goal of becoming a global top 10 drugmaker.
* Also needs approval from Takeda, Shire shareholders (Adds share movement)
TOKYO, July 10 Japan's Takeda Pharmaceutical Co Ltd said on Tuesday it received a key U.S. regulatory approval for its $62 billion deal to buy London-listed Shire Plc .
TOKYO Japan's Takeda Pharmaceutical Co Ltd is selling its Osaka headquarters amid concerns over its finances due to its $62 billion deal to buy London-listed Shire Plc , the Nikkei business daily reported on Thursday.
TOKYO, July 5 Japan's Takeda Pharmaceutical Co Ltd is selling its Osaka headquarters amid concerns over its finances due to its $62 billion deal to buy London-listed Shire Plc, the Nikkei business daily reported on Thursday.
Hong Kong, June 29 (TRLPC) - Syndicated lending in Asia Pacific, excluding Japan, showed a steep 31% year-on-year decline to US$94.17bn in the second quarter, dragging first-half borrowing volumes down 9.2% to US$211.60bn, according to Thomson Reuters LPC data.
LONDON A resurgence in mega-deals has led to a doubling of mergers and acquisitions activity in Europe so far this year, raising questions among bankers and lawyers about when the pace of blockbuster transactions will start to fade.